Free Trial

Needham & Company LLC Reiterates "Buy" Rating for Cooper Companies (NASDAQ:COO)

Cooper Companies logo with Medical background

Key Points

  • Needham & Company LLC has reaffirmed its "buy" rating for Cooper Companies (NASDAQ: COO), setting a price target of $94, indicating a potential upside of 26.84% from its previous closing price.
  • Despite Needham's optimistic outlook, other analysts like Wall Street Zen downgraded the stock to a "hold" rating, while JPMorgan Chase & Co. and Mizuho revised their price targets downward to $76 and $90 respectively.
  • Cooper Companies reported earnings of $1.10 per share for the last quarter, surpassing expectations, and forecasts indicate an EPS guidance of 1.100-1.140 for Q4 2025.
  • Need better tools to track Cooper Companies? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Cooper Companies (NASDAQ:COO - Get Free Report)'s stock had its "buy" rating reaffirmed by equities research analysts at Needham & Company LLC in a research report issued on Thursday,Benzinga reports. They presently have a $94.00 price objective on the medical device company's stock. Needham & Company LLC's price objective suggests a potential upside of 26.84% from the company's previous close.

Other analysts also recently issued research reports about the stock. Wall Street Zen downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Piper Sandler reiterated an "overweight" rating and issued a $105.00 target price (down previously from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $76.00 target price (down previously from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Wells Fargo & Company cut their price target on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a report on Friday, May 30th. Finally, Mizuho cut their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $96.73.

View Our Latest Analysis on Cooper Companies

Cooper Companies Stock Up 0.6%

Shares of NASDAQ COO opened at $74.11 on Thursday. The stock has a market capitalization of $14.82 billion, a P/E ratio of 35.98, a P/E/G ratio of 1.80 and a beta of 1.00. The company has a 50-day moving average price of $72.44 and a 200-day moving average price of $77.88. Cooper Companies has a 1 year low of $65.00 and a 1 year high of $112.38. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.07 by $0.03. The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The firm's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities research analysts forecast that Cooper Companies will post 3.98 EPS for the current fiscal year.

Institutional Investors Weigh In On Cooper Companies

Several large investors have recently added to or reduced their stakes in the company. Orion Porfolio Solutions LLC increased its holdings in Cooper Companies by 840.5% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 96,592 shares of the medical device company's stock worth $6,873,000 after acquiring an additional 86,322 shares during the last quarter. Squarepoint Ops LLC increased its holdings in Cooper Companies by 116.5% in the 2nd quarter. Squarepoint Ops LLC now owns 42,134 shares of the medical device company's stock worth $2,998,000 after acquiring an additional 22,676 shares during the last quarter. State of Wyoming bought a new position in Cooper Companies in the 2nd quarter worth about $220,000. Westwood Holdings Group Inc. boosted its stake in Cooper Companies by 23.4% in the 2nd quarter. Westwood Holdings Group Inc. now owns 311,745 shares of the medical device company's stock worth $22,184,000 after purchasing an additional 59,190 shares during the period. Finally, CYBER HORNET ETFs LLC bought a new position in Cooper Companies in the 2nd quarter worth about $36,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Company Profile

(Get Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Stories

Analyst Recommendations for Cooper Companies (NASDAQ:COO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines